Brief: Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
11/08/2026 13:36
BRIEF-Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027 Aug 11 (Reuters) - Bicara Therapeutics Inc BCAX.O:
BICARA THERAPEUTICS REPORTS SECOND QUARTER 2026 PROGRESS AND ANNOUNCES STRATEGIC LEADERSHIP TRANSITIONS MARKING NEXT ERA OF EXECUTION AND GROWTH
BICARA THERAPEUTICS - APPOINTS RYAN COHLHEPP AS PRESIDENT & CEO EFFECTIVE JANUARY 2027
BICARA THERAPEUTICS - APPOINTS JENN LARSON AS CFO EFFECTIVE AUGUST 12, 2026
Source text: ID:nGNXbM4VZ4
Further company coverage: BCAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bicara Therapeutics
See all newsBrief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Bicara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
Brief: Bicara Therapeutics Announces Appointments Of Jeremy Bender And Christy Oliger To Board Of Directors